Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.1.7 Variant

Paul T. Heath, Eva P. Galiza, David Neil Baxter, Marta Boffito, Duncan Browne, Fiona Burns, David R. Chadwick, Rebecca Clark, Catherine Cosgrove, James Galloway, Anna L. Goodman, Amardeep Heer, Andrew Higham, Shalini Iyengar, Arham Jamal, Christopher Jeanes, Philip A. Kalra, Christina Kyriakidou, Daniel F. McAuley, Agnieszka Meyrick, Angela M. Minassian, Jane Minton, Patrick Moore, Imrozia Munsoor, Helen Nicholls, Orod Osanlou, Jonathan Packham, Carol H. Pretswell, Alberto San Francisco Ramos, Dinesh Saralaya, Ray P. Sheridan, Richard Smith, Roy L. Soiza, Pauline A. Swift, Emma C. Thomson, Jeremy Turner, Marianne Elizabeth Viljoen, Gary Albert, Iksung Cho, Filip Dubovsky, Greg Glenn, Joy Rivers, Andreana Robertson, Kathy Smith, Seth Toback
doi: https://doi.org/10.1101/2021.05.13.21256639

Article Information

doi 
https://doi.org/10.1101/2021.05.13.21256639
History 
  • May 14, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Paul T. Heath, FRCPCH1,
  2. Eva P. Galiza, MBBS1,
  3. David Neil Baxter, MD, PhD2,
  4. Marta Boffito, MD, PhD3,
  5. Duncan Browne, MD4,
  6. Fiona Burns, PhD5,
  7. David R. Chadwick, PhD6,
  8. Rebecca Clark, MBChB7,
  9. Catherine Cosgrove, PhD1,
  10. James Galloway, PhD8,
  11. Anna L. Goodman, DPhil9,
  12. Amardeep Heer, MBChB10,
  13. Andrew Higham, PhD11,
  14. Shalini Iyengar, MBBS12,
  15. Arham Jamal, MBBCH13,
  16. Christopher Jeanes, MBBS14,
  17. Philip A. Kalra, MD15,
  18. Christina Kyriakidou, MD16,
  19. Daniel F. McAuley, MD17,
  20. Agnieszka Meyrick, MD18,
  21. Angela M. Minassian, DPhil19,
  22. Jane Minton, PhD20,
  23. Patrick Moore, BScBM21,
  24. Imrozia Munsoor, MBBS22,
  25. Helen Nicholls, MBBCh23,
  26. Orod Osanlou, MBChB24,
  27. Jonathan Packham, DM25,
  28. Carol H. Pretswell, MBChB26,
  29. Alberto San Francisco Ramos, MB1,
  30. Dinesh Saralaya, MD27,
  31. Ray P. Sheridan, MBChB28,
  32. Richard Smith, PhD29,
  33. Roy L. Soiza, MBChB30,
  34. Pauline A. Swift, PhD31,
  35. Emma C. Thomson, PhD32,
  36. Jeremy Turner, DPhil (Oxon)14,
  37. Marianne Elizabeth Viljoen, MBChB33,
  38. Gary Albert, MS34,
  39. Iksung Cho, MS34,
  40. Filip Dubovsky, MD34,
  41. Greg Glenn, MD34,
  42. Joy Rivers, PhD34,
  43. Andreana Robertson, MS34,
  44. Kathy Smith, MD34 and
  45. Seth Toback, MD34,*
  1. 1Vaccine Institute, St. George’s, University of London and St. Georges University Hospitals NHS Foundation Trust, London, UK
  2. 2Stockport NHS Foundation Trust, Stepping Hill Hospital, Poplar Grove, Stockport, UK
  3. 3Chelsea and Westminster Hospital NHS Foundation Trust and Imperial College London, London, UK
  4. 4Royal Cornwall Hospitals NHS Trust, Truro, UK
  5. 5Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust, London, UK
  6. 6Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough, UK
  7. 7Layton Medical Centre, Blackpool, UK
  8. 8Centre for Rheumatic Disease, Kings College London, London, UK
  9. 9Department of Infectious Diseases, Guy’s and St Thomas’ NHS Foundation Trust, and MRC Clinical Trials Unit at University College London, London, UK
  10. 10Lakeside Healthcare Research, Lakeside Surgeries Corby, Northants, UK
  11. 11University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal, UK
  12. 12Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham, UK
  13. 13Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Wellington House, Worton Drive, Worton Grange, Reading, UK
  14. 14Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, Norfolk, UK
  15. 15Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford, UK
  16. 16Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham Research Park, Birmingham, UK
  17. 17Wellcome-Wolfson Institute for Experimental Medicine, Queen’s University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK
  18. 18Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Burlington House, Waterloo, Liverpool, UK
  19. 19Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, UK
  20. 20St James’s University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK
  21. 21The Adam Practice, Poole, Dorset, UK, and University Hospital Southampton NHS Foundation Trust, Southampton, UK
  22. 22Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site, Venture Building, Kelvin Campus, Glasgow, Scotland, UK
  23. 23Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Riverside Court Gwaelod-y-Garth, Cardiff, Wales, UK
  24. 24School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Wales, UK
  25. 25Division of Epidemiology and Public Health, University of Nottingham, Nottingham UK, and Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford, UK
  26. 26Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Matrix Park Buckshaw Village, Chorley, Lancashire, UK
  27. 27National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK
  28. 28Royal Devon & Exeter Hospital, Exeter, Devon, UK
  29. 29East Suffolk and North Essex NHS Foundation Trust and University of Essex, Wivenhoe Park, Colchester, Essex, UK
  30. 30Aberdeen Royal Infirmary, NHS Grampian, and Ageing Clinical and Experimental Research (ACER) Group, University of Aberdeen, Aberdeen, Scotland, UK
  31. 31Renal Services, Epsom and St Helier University Hospitals NHS Trust, London, UK
  32. 32MRC-University of Glasgow Centre for Virus Research, and Queen Elizabeth University Hospital, NHS Greater Glasgow & Clyde, Glasgow, Scotland, UK
  33. 33Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Kilburn House, Manchester, UK
  34. 34Novavax, Inc., Gaithersburg, MD, USA
  1. ↵*Corresponding author:
    Seth Toback, MD, Novavax, Inc., 21 Firstfield Rd., Gaithersburg, MD, 20878; stoback{at}novavax.com
Back to top
Posted May 14, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.1.7 Variant
Paul T. Heath, Eva P. Galiza, David Neil Baxter, Marta Boffito, Duncan Browne, Fiona Burns, David R. Chadwick, Rebecca Clark, Catherine Cosgrove, James Galloway, Anna L. Goodman, Amardeep Heer, Andrew Higham, Shalini Iyengar, Arham Jamal, Christopher Jeanes, Philip A. Kalra, Christina Kyriakidou, Daniel F. McAuley, Agnieszka Meyrick, Angela M. Minassian, Jane Minton, Patrick Moore, Imrozia Munsoor, Helen Nicholls, Orod Osanlou, Jonathan Packham, Carol H. Pretswell, Alberto San Francisco Ramos, Dinesh Saralaya, Ray P. Sheridan, Richard Smith, Roy L. Soiza, Pauline A. Swift, Emma C. Thomson, Jeremy Turner, Marianne Elizabeth Viljoen, Gary Albert, Iksung Cho, Filip Dubovsky, Greg Glenn, Joy Rivers, Andreana Robertson, Kathy Smith, Seth Toback
medRxiv 2021.05.13.21256639; doi: https://doi.org/10.1101/2021.05.13.21256639
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area